Last updated: 1 July 2024 at 5:36pm EST

Akshay Vaishnaw Net Worth




The estimated Net Worth of Akshay Vaishnaw is at least $26.1 Milion dollars as of 3 August 2023. Akshay Vaishnaw owns over 4,057 units of Alnylam Pharmaceuticals Inc stock worth over $5,964,738 and over the last 15 years he sold ALNY stock worth over $17,083,794. In addition, he makes $3,100,950 as President - Research and Development at Alnylam Pharmaceuticals Inc.

Akshay Vaishnaw ALNY stock SEC Form 4 insiders trading

Akshay has made over 36 trades of the Alnylam Pharmaceuticals Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 4,057 units of ALNY stock worth $753,993 on 3 August 2023.

The largest trade he's ever made was exercising 88,554 units of Alnylam Pharmaceuticals Inc stock on 14 March 2018 worth over $1,508,075. On average, Akshay trades about 6,536 units every 46 days since 2009. As of 3 August 2023 he still owns at least 22,774 units of Alnylam Pharmaceuticals Inc stock.

You can see the complete history of Akshay Vaishnaw stock trades at the bottom of the page.





Akshay Vaishnaw biography

Dr. Akshay K. Vaishnaw M.D., Ph.D. is President - Research and Development of the Alnylam Pharmaceuticals, Inc. He was our Executive Vice President of Research and Development from December 2014 to March 2018 and our Chief Medical Officer from June 2011 to December 2016. He served as our Executive Vice President from June 2012 to December 2014 and prior to that as our Senior Vice President from June 2011 to June 2012. He served as our Senior Vice President, Clinical Research from December 2008 to June 2011, and prior to that served as our Vice President, Clinical Research from the time he joined us in January 2006. From December 1998 through December 2005, Dr. Vaishnaw held various positions at Biogen Inc., a biopharmaceutical company. Dr. Vaishnaw serves as a member of the board of directors of Editas Medicine, Inc.

What is the salary of Akshay Vaishnaw?

As the President - Research and Development of Alnylam Pharmaceuticals Inc, the total compensation of Akshay Vaishnaw at Alnylam Pharmaceuticals Inc is $3,100,950. There are 4 executives at Alnylam Pharmaceuticals Inc getting paid more, with John Maraganore having the highest compensation of $7,317,860.



How old is Akshay Vaishnaw?

Akshay Vaishnaw is 57, he's been the President - Research and Development of Alnylam Pharmaceuticals Inc since 2018. There are 15 older and 2 younger executives at Alnylam Pharmaceuticals Inc. The oldest executive at Alnylam Pharmaceuticals Inc is Phillip Sharp, 75, who is the Independent Director.

What's Akshay Vaishnaw's mailing address?

Akshay's mailing address filed with the SEC is 301, Binney Street, East Cambridge, Cambridge, Middlesex County, Massachusetts, 02142, United States.

Insiders trading at Alnylam Pharmaceuticals Inc

Over the last 20 years, insiders at Alnylam Pharmaceuticals Inc have traded over $140,068,015 worth of Alnylam Pharmaceuticals Inc stock and bought 4,419,116 units worth $1,983,132,563 . The most active insiders traders include Sanofi, Christoph H Westphal oraz Kevin P Starr. On average, Alnylam Pharmaceuticals Inc executives and independent directors trade stock every 23 days with the average trade being worth of $11,181,724. The most recent stock trade was executed by Yvonne Greenstreet on 20 August 2024, trading 15,000 units of ALNY stock currently worth $1,275,000.



What does Alnylam Pharmaceuticals Inc do?

alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.



What does Alnylam Pharmaceuticals Inc's logo look like?

Alnylam Pharmaceuticals Inc logo

Complete history of Akshay Vaishnaw stock trades at Alnylam Pharmaceuticals Inc, Editas Medicine Inc oraz Scholar Rock Corp

Data
#
Firma
Osoba
Trans.
Transakcja
Ilość akcji Cena za akcję Łączna cena Ilość akcji po Źródło
3 Aug 2023 Akshay Vaishnaw
Prezydent
Sprzedaż 4,057 $185.85 $753,993
3 Aug 2023
22,774
26 Apr 2023 Akshay Vaishnaw
Prezydent
Sprzedaż 2,392 $194.59 $465,459
26 Apr 2023
17,890
10 Feb 2023 Akshay Vaishnaw
Prezydent
Sprzedaż 38,044 $215.97 $8,216,363
10 Feb 2023
14,970
5 Dec 2022 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 5,079 $59.05 $299,915
5 Dec 2022
23,425
21 Dec 2021 Akshay Vaishnaw
Prezydent
Sprzedaż 2,879 $190.93 $549,687
21 Dec 2021
11,215
9 Aug 2021 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 10,834 $63.00 $682,542
9 Aug 2021
22,049
18 Jun 2021 Akshay Vaishnaw
Prezydent
Sprzedaż 14,708 $175.00 $2,573,900
18 Jun 2021
11,215
19 Apr 2021 Akshay Vaishnaw
Prezydent
Sprzedaż 6,438 $137.36 $884,324
19 Apr 2021
14,119
29 Sep 2020 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 971 $42.22 $40,996
29 Sep 2020
15,090
22 Jun 2020 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 970 $42.22 $40,953
22 Jun 2020
15,089
20 Apr 2020 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 21,971 $42.22 $927,616
20 Apr 2020
36,090
7 Feb 2020 Akshay Vaishnaw
Prezydent
Sprzedaż 23,708 $125.00 $2,963,500
7 Feb 2020
11,215
14 Mar 2018 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 88,554 $17.03 $1,508,075
14 Mar 2018
99,769
30 Oct 2017 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 33,666 $21.35 $718,769
30 Oct 2017
45,201
13 Jun 2017 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 1,668 $19.19 $32,009
13 Jun 2017
11,965
23 May 2017 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 11,000 $21.35 $234,850
23 May 2017
21,297
15 May 2017 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 43,750 $28.87 $1,263,063
15 May 2017
21,297
30 Dec 2016 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 9,547 $19.61 $187,217
30 Dec 2016
15,297
30 Nov 2016 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 29,165 $22.75 $663,504
30 Nov 2016
34,915
25 Nov 2015 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 5,750 $17.35 $99,763
25 Nov 2015
5,750
16 Jun 2015 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 8,750 $8.67 $75,863
16 Jun 2015
8,750
17 Mar 2015 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 8,750 $8.67 $75,863
17 Mar 2015
8,750
12 Dec 2014 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 10,626 $8.75 $92,978
12 Dec 2014
10,626
16 Sep 2014 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 10,625 $8.75 $92,969
16 Sep 2014
10,625
17 Jun 2014 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 10,625 $8.75 $92,969
17 Jun 2014
10,625
18 Mar 2014 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 32,769 $11.60 $380,120
18 Mar 2014
32,769
23 Jan 2014 Akshay Vaishnaw
Prezydent
Sprzedaż 7,890 $85.75 $676,568
23 Jan 2014
0
16 Dec 2013 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 33,480 $10.97 $367,276
16 Dec 2013
31,068
10 Sep 2013 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 6,250 $9.30 $58,125
10 Sep 2013
18,838
11 Jun 2013 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 15,000 $8.53 $127,950
11 Jun 2013
17,588
11 Mar 2013 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 6,250 $9.30 $58,125
11 Mar 2013
18,838
10 Dec 2012 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 14,777 $8.55 $126,343
10 Dec 2012
22,588
4 Dec 2012 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 2,400 $7.10 $17,040
4 Dec 2012
14,988
30 Nov 2012 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 2,823 $7.10 $20,043
30 Nov 2012
15,411
10 Sep 2012 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 6,250 $9.30 $58,125
10 Sep 2012
17,504
16 Jul 2012 Akshay Vaishnaw
Prezydent
Opcja Ćwiczenie 36,250 $9.25 $335,313
16 Jul 2012
23,838


Alnylam Pharmaceuticals Inc executives and stock owners

Alnylam Pharmaceuticals Inc executives and other stock owners filed with the SEC include: